Barr Pharmaceuticals, Inc. Exec...( MONTVALE N.J. March 28 /- ...),Health

MONTVALE, N.J., March 28 /PRNewswire/ --

Christine A. Mundkur, Esq.

Chief Executive Officer,

Barr Laboratories, Inc.

-- In this newly created position, Mundkur has responsibility for Barr's

global generics business, including strategic planning, research and

development, regulatory affairs, operations, quality, and sales and

marketing. Under her leadership, Barr Laboratories will continue to

support the proprietary business in the areas of formulation,

regulatory affairs, and product supply.

-- Most recently served as Executive Vice President, Global Quality,

Safety and Regulatory Affairs, with responsibility for leading the

Company's Global Quality, Safety, PK/BE and Regulatory Affairs

Operations.

-- Barr: 15 years

* Joined Barr In 1993 As An Associate Counsel.

* Named Director Of Regulatory Affairs and Regulatory Counsel In

1997.

* Promoted to Vice President, Quality And Regulatory Counsel In 1998.

* Promoted to Sr. Vice President Quality and Regulatory Counsel in

2001.

* Promoted to Executive Vice President In 2007.

-- Bachelor of Science in Chemistry from Saint Louis University.

-- Juris Doctorate from Saint Louis University School of Law.

G. Frederick Wilkinson

Chief Executive Officer,

Duramed Pharmaceuticals, Inc.

-- In this newly created position, Wilkinson has responsibility for all

functions related to product selection, clinical development, and sales

and marketing. He will also continue directing Barr's growing global

biologics development program and for providing the strategic direction

and coordination of the Company's global business develo
'/>"/>